QCLS SCHEDULE 13D/A: Activist campaign

Q/C TECHNOLOGIES, INC.

Filed with the SEC on · accession 0001683168-26-009020

Q/C TECHNOLOGIES, INC. (QCLS) filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 20, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -5.9% by the first close after the filing.

Summary of the filing

PharmaCyte Biotech, Inc. filed an amended Schedule 13D disclosing it beneficially owns 49.99% of Q/C Technologies, Inc. after acquiring 4,982,272 shares via a warrant exchange and amending preferred stock and warrant terms to extend Series H maturity and adjust beneficial ownership limits.

Key details

Shares of Common Stock beneficially owned$8.4M
Shares of Common Stock acquired in warrant exchange$5.0M
Series G Long-Term Warrants exchanged$851K
Closing price per share used for exchange calculation$0
Reporting person / beneficial ownerPharmaCyte Biotech, Inc.
Issuer / subject companyQ/C Technologies, Inc.
Contact for reporting personCarlos Trujillo

How QCLS stock reacted

Close before

$0.30

Nov 19, 2026

First close after

-5.95%

$0.28

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for QCLS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QCLS?

Click here

Frequently asked questions

What did QCLS file with the SEC on Nov 20, 2026?

QCLS filed a SCHEDULE 13D/A (Activist campaign). PharmaCyte Biotech, Inc. filed an amended Schedule 13D disclosing it beneficially owns 49.99% of Q/C Technologies, Inc. after acquiring 4,982,272 shares via a warrant exchange and amending preferred stock and warrant terms to extend Series H maturity and adjust beneficial ownership limits.

What does a activist campaign mean for QCLS stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did QCLS stock react to this filing?

QCLS closed at $0.30 before the filing and $0.28 on Nov 20, 2026 (-5.95%).

Other QCLS SEC filings

Get alerts when QCLS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days